4Satoru N,Tatsuo K,Shin-icK K,et al. Reurrence pattem of squamous cell carcinom of the thoracic esophagus after extended radical esophgec- tomy with three field lymphadenectonly [J]. Am Coil Surg,2004,198(2) : 205-211.
5Hamasaki M,Noda T,Ohsumi Y. The early secretory pathway contributes to autopha in yeast [Jl. Cell Struct Funct,2008,28( 1 ):49-54.
6YasudaT,KabutoT,IshiguroS,et a].Preoperativeneoadjuvant chemotherapy with a combination of 5-fluolmuraeil, adriamycin and cisplatin (FAP)for advaned esophageal cancer invading trachea or main bronchus [J]. Gan To Kagaku Ryoho, 2005,32( 11 ) : 1538-1541.
7Rigas JR,Dragnev KH,Bubis JA. Docetaxel in the treatment of esophageal cancer [J]. Sem in One,2005,32(4) :39-51.
8Klanber N,Parangi S,Flynn E,et al. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-Methoxyestra- diol and paclitaxe [J]. Cancer Res, 2007,57 ( 1 ) : 81.
9Blazeby JM,Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for esophageal cancer [J]. Gut,2001,49 ( 2 ) : 227-230.
